Success of Big Infectious Disease Reimbursement Policy in China

Nie, Kun-xi; Wang, Chan; Li, Xin-wu

This article extends the infectious disease model to introduce the big infectious disease reimbursement policy in China and shows why this reimbursement policy is successful. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. Therefore, it is necessary to launch full reimbursement policy for infectious diseases under high expenditures incurred by treatment condition. The higher the treatment costs, the more important the government intervention. The conclusions of this article offer theoretical support to control big infectious diseases. Moreover, for emerging infectious diseases, uncertainty yields high treatment expenditures and the government should establish complete reimbursement policy to control these diseases. However, the limitation of this article is lack of data verification of medical expenditures about big infectious disease from China and the United States. In addition, predicting infectious diseases using learning and big data may be the subject of future study. Numerical Simulation Results.